Essays on the Drug Discovery Innovation System

Simple item page
dc.contributor.advisorHart, David M
dc.contributor.authorSarkissian, Alfred
dc.creatorSarkissian, Alfred
dc.date.accessioned2018-10-22T01:20:33Z
dc.date.available2018-10-22T01:20:33Z
dc.date.issued2017
dc.description.abstractDespite the increase in scientific, monetary, and human resources devoted to drug discovery R&D, the annual number of FDA-approved drugs has been almost unchanged for decades. This study seeks clues to the R&D productivity paradox by exploring the drivers and barriers to innovation in the pharmaceutical industry. The main focus is on the contribution of science and knowledge form external sources to innovation.
dc.format.extent294 pages
dc.identifier.urihttps://hdl.handle.net/1920/11297
dc.language.isoen
dc.rightsCopyright 2017 Alfred Sarkissian
dc.subjectPublic policy
dc.subjectBreakthrough Innovations
dc.subjectDrug Discovery Innovation
dc.subjectEroom’s Law
dc.subjectInnovation System
dc.subjectOrange Book
dc.subjectPatent Analysis
dc.titleEssays on the Drug Discovery Innovation System
dc.typeDissertation
thesis.degree.disciplinePublic Policy
thesis.degree.grantorGeorge Mason University
thesis.degree.levelPh.D.

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Sarkissian_gmu_0883E_11596.pdf
Size:
2.54 MB
Format:
Adobe Portable Document Format
Download

Collections

Schar School of Policy and Government